Le Lézard
Classified in: Health
Subjects: RCL, PSF

Advisory - Certain vials of fertility drug Cetrotide recalled because of potential contamination


OTTAWA, ON, July 4, 2020 /CNW/ -

Summary
Products: Cetrotide 0.25mg

Issue: One lot of Cetrotide 0.25mg is being recalled because some vials may have missing stoppers, which could make the product unsterile.

What to do: Check the lot number on your product or contact your pharmacist to determine whether your product is subject to this recall. If you have a recalled product, do not take the medication. Contact your healthcare provider as soon as possible to obtain a replacement and avoid any interruption to your treatment.

Issue
Health Canada is advising Canadians that EMD Serono, a Division of EMD Inc. Canada, is recalling one lot of Cetrotide 0.25mg because some vials may have missing stoppers, which could make the product unsterile.

Cetrotide is used in fertility treatment to help women get pregnant by stopping the body from releasing an egg from the ovary (ovulation) early so that it can be released at the best time for pregnancy to occur.

An unsterile product could introduce microorganisms when injected under the patient's skin. This may result in a local infection, such as an abscess, or an infection of the skin and deeper underlying tissues (cellulitis). Some infections can be serious if they spread to the blood, bones, heart or other areas of the body.

In addition, some of the contents of the vial may have spilled out because of the missing stopper, so the patient may not receive the proper dose and the drug would not be as effective.

Health Canada will monitor the company's recall and inform Canadians if new safety information becomes available.

Who is affected
Patients who are taking Cetrotide 0.25mg.

Affected product

Company

Product Name

DIN

Strength

Lot

Expiry

EMD Serono, a Division of EMD Inc. Canada

Cetrotide

02247766

0.25mg

8J025C

09/2020

What consumers should do

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 11:01
Vyne, a recognized market leader in health information exchange and electronic healthcare communication management, announced today a rebrand of its dental business. The Vyne Dental® brand reflects the company's evolution into a complete revenue...

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 123 new cases, bringing the total number of people infected to 59,722. During the same period, 1 new death was recorded, to which is added 1 death that occurred before July 26, for a total...

at 11:00
As the COVID-19 pandemic continues nationally and worldwide, TIDI Products is committed to supporting those on the front lines, and has developed a new PPE option to help keep healthcare providers safe....

at 11:00
According to Stratistics MRC, the Global Blood Glucose Monitoring Systems Market is accounted for $9.45 billion in 2019 and is expected to reach $15.41 billion by 2027 growing at a CAGR of 6.3% during the forecast period. Some of the key players...

at 11:00
The global syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019?2025. Key Highlights Offered in the Report:   Safety needles are the major leading segment and are growing at a faster growth rate, thereby...

at 11:00
Front Desk Supply, a leading hospitality supplier based in San Diego, CA, announced today two specials for hotels - the first is a free 50-pack of face masks with any PPE purchase of $200 or more, and the second is $35 off any notepads order. The...



News published on 4 july 2020 at 16:12 and distributed by: